Literature DB >> 8932354

What do cancer patients mean when they complain of concentration and memory problems?

A Cull1, C Hay, S B Love, M Mackie, E Smets, M Stewart.   

Abstract

Cognitive function items are increasingly included in quality of life measures, and complaints of concentration and memory difficulties are often reported by cancer patients. The aim of this study was to examine the factors influencing patients' level of complaint by comparing subjective reports with objective test performance of a sample of adult lymphoma patients, disease-free and > or = 6 months after treatment. There was no significant difference between complainers and non-complainers in sociodemographic or clinical characteristics or in their performance on standard neuropsychometric tests of concentration and memory. Those reporting concentration and memory difficulties had significantly higher scores on measures of anxiety, depression and fatigue. This calls into question the validity of including cognitive function items in self-report quality of life measures. Patients who report concentration and memory difficulties should be screened for clinically significant and potentially remediable mood disorder. Objective testing remains the method of choice for assessing higher mental function.

Entities:  

Mesh:

Year:  1996        PMID: 8932354      PMCID: PMC2074867          DOI: 10.1038/bjc.1996.608

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Professional rehabilitation of lymphoma patients: a study of psychosocial factors associated with return to work.

Authors:  D Razavi; N Delvaux; A Brédart; P Autier; D Bron; L Debusscher; P Stryckmans
Journal:  Support Care Cancer       Date:  1993-09       Impact factor: 3.603

2.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

3.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

4.  Epilepsy and poor memory: who complains and what do they mean?

Authors:  R Corcoran; P Thompson
Journal:  Br J Clin Psychol       Date:  1993-05

5.  The relation between subjective and objective memory impairment after stroke.

Authors:  N B Lincoln; D J Tinson
Journal:  Br J Clin Psychol       Date:  1989-02

6.  Psychosocial problems among survivors of Hodgkin's disease.

Authors:  P Fobair; R T Hoppe; J Bloom; R Cox; A Varghese; D Spiegel
Journal:  J Clin Oncol       Date:  1986-05       Impact factor: 44.544

7.  Screening for anxiety and depression in cancer patients: the effects of disease and treatment.

Authors:  T Ibbotson; P Maguire; P Selby; T Priestman; L Wallace
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

8.  A brief mental fatigue questionnaire.

Authors:  R P Bentall; G C Wood; T Marrinan; C Deans; R H Edwards
Journal:  Br J Clin Psychol       Date:  1993-09

9.  Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist.

Authors:  J C de Haes; F C van Knippenberg; J P Neijt
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

Review 10.  Fatigue in cancer patients.

Authors:  E M Smets; B Garssen; A L Schuster-Uitterhoeve; J C de Haes
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

View more
  36 in total

1.  Short-term monitoring of cognitive functions before and during the first course of treatment.

Authors:  Barbara Eberhardt; Stefan Dilger; Frauke Musial; Ulrich Wedding; Thomas Weiss; Wolfgang H R Miltner
Journal:  J Cancer Res Clin Oncol       Date:  2006-01-14       Impact factor: 4.553

Review 2.  Memory and cancer: a review of the literature.

Authors:  Graham J McDougall; JoAnn S Oliver; Forrest Scogin
Journal:  Arch Psychiatr Nurs       Date:  2014-03-22       Impact factor: 2.218

3.  Radiotherapy for malignant glioma.

Authors:  A Gregor; A Cull
Journal:  BMJ       Date:  1996-12-14

Review 4.  Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy.

Authors:  Xiao-Min Wang; Brian Walitt; Leorey Saligan; Agnes F Y Tiwari; Chi Wai Cheung; Zhang-Jin Zhang
Journal:  Cytokine       Date:  2015-01-05       Impact factor: 3.861

5.  Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma.

Authors:  Karin Gehring; Martin J B Taphoorn; Margriet M Sitskoorn; Neil K Aaronson
Journal:  Neurooncol Pract       Date:  2015-03-03

6.  Medium-term effects of chemotherapy in older cancer patients.

Authors:  Barbara Eberhardt; Stefan Dilger; Frauke Musial; Ulrich Wedding; Thomas Weiss; Wolfgang H R Miltner
Journal:  Support Care Cancer       Date:  2005-11-04       Impact factor: 3.603

7.  The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9.

Authors:  Debra L Barton; Kelli Burger; Paul J Novotny; Tom R Fitch; Sadhna Kohli; Gamini Soori; Mary Beth Wilwerding; Jeff A Sloan; Lisa A Kottschade; Kendrith M Rowland; Shaker R Dakhil; Daniel A Nikcevich; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2012-11-13       Impact factor: 3.603

8.  Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report.

Authors:  Kathleen Meeske; Ashley Wilder Smith; Catherine M Alfano; Bonnie A McGregor; Anne McTiernan; Kathy B Baumgartner; Kathleen E Malone; Bryce B Reeve; Rachel Ballard-Barbash; Leslie Bernstein
Journal:  Qual Life Res       Date:  2007-04-25       Impact factor: 4.147

9.  Fatigue in patients with adjuvant radiation therapy for breast cancer: long-term follow-up.

Authors:  Hans Geinitz; Frank B Zimmermann; Reinhard Thamm; Monika Keller; Raymonde Busch; Michael Molls
Journal:  J Cancer Res Clin Oncol       Date:  2004-03-06       Impact factor: 4.553

Review 10.  Health-related quality of life in patients with high-grade glioma.

Authors:  Jin-xiang Cheng; Xiang Zhang; Bo-Lin Liu
Journal:  Neuro Oncol       Date:  2008-07-15       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.